These data indicate that a delayed regimen of the pharmacological inhibition of NHE1 protein activity with HOE642 from 24 h post-stroke attenuated OL apoptosis and stimulated OL genesis, leading to improved white matter myelination in post-stroke brains. The gene discussed is SLC9A1; the disease is stroke disorder.